+1 (800) 638-8174
+1 (800) 521-0390
+ 32 87 321 611
+ 32 87 321 611
Contact your local Lonza Distributor
Tel: +1 (800) 638-8174
Fax: +1 301 845 8291
Download a copy of our new white paper, Low Endotoxin Recovery: Beyond the Controversy.
Download LER White Paper
What is Low Endotoxin Recovery (LER)?
Low Endotoxin Recovery (LER) is a controversial topic that has been circulating throughout the endotoxin detection community for the last two years. This phenomenon is hypothetically described as a “masking effect” manifested in the biophysical formation of a complex that blocks the ability of Factor C, the main component in LAL detection, to bind endotoxin (J. Chen, Low Endotoxin Recovery in Common Biologics Products, presented at the 2013 Annual PDA Meeting, Orlando, FL, April 2013).
Two common drug excipients, polysorbate and citrate, have been identified as probable causes of the masking effect more commonly referred to as LER. These substances are estimated to be used in more than 70% of protein formulations (Maggio, 2012). There is also some evidence that phosphate-containing formulations may also be affected by LER. However, the LER effect has only been observed in combination formulations of the aforementioned excipients, and not in individual raw materials.
Want to learn more? Schedule an on-site LER seminar with our Lonza team.
Register and become a QC Insider™
to access our new technical tip:
Low Endotoxin Recovery - Frequently Asked Questions
Already a subscriber? Click on LER-FAQs and input your username and password on the login page. You will then be directed to the QC Insider Library, Tech Tips page to download the technical tip.
The Use of Endotoxin as an Analyte in Biopharmaceutical Product Hold-Time Studies
Low Endotoxin Recovery (LER) in Drug Products
Polysorbates, Immunogenicity, and the Totality of Evidence
Endotoxin Test Concerns of Biologics: LER From a Broad Biologics Test Perspective
LER: Microbiology's Hottest Urban Myth